Literature DB >> 23414590

Brain metastases in HER2-positive breast cancer.

Nancy U Lin1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23414590     DOI： 10.1016/S1470-2045(13)70046-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  8 in total

1.  Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain?

Authors:  Sheheryar Kabraji; Jing Ni; Nancy U Lin; Shaozhen Xie; Eric P Winer; Jean J Zhao
Journal:  Clin Cancer Res       Date:  2018-02-06       Impact factor: 12.531

2.  Trastuzumab-Resistant Luminal B Breast Cancer Cells Show Basal-Like Cell Growth Features Through NF-κB-Activation.

Authors:  Hirotaka Kanzaki; Nishit K Mukhopadhya; Xiaojiang Cui; V Krishnan Ramanujan; Ramachandran Murali
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2016-01-21

3.  Role of HER2 status in the treatment for brain metastases arising from breast cancer with stereotactic radiosurgery.

Authors:  Moses Tam; Ashwatha Narayana; Shahzad Raza; Saroj Kunnakkat; John G Golfinos; Erik C Parker; Yelena Novik
Journal:  Med Oncol       Date:  2014-01-05       Impact factor: 3.064

Review 4.  CNS metastases in breast cancer: old challenge, new frontiers.

Authors:  Nancy U Lin; Laleh Amiri-Kordestani; Diane Palmieri; David J Liewehr; Patricia S Steeg
Journal:  Clin Cancer Res       Date:  2013-12-01       Impact factor: 12.531

5.  Therapeutic Considerations in Treating HER2-Positive Metastatic Breast Cancer.

Authors:  Ciara C O'Sullivan; Karen L Smith
Journal:  Curr Breast Cancer Rep       Date:  2014-09-01

6.  NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer.

Authors:  Chris E Adkins; Mohamed I Nounou; Tanvirul Hye; Afroz S Mohammad; Tori Terrell-Hall; Neel K Mohan; Michael A Eldon; Ute Hoch; Paul R Lockman
Journal:  BMC Cancer       Date:  2015-10-13       Impact factor: 4.430

7.  Health-related quality of life and work productivity in UK patients with HER2-positive breast cancer: a cross-sectional study evaluating the relationships between disease and treatment stage.

Authors:  Mark Verrill; Andrew M Wardley; Jenny Retzler; Adam B Smith; Catherine Bottomley; Sorcha Ní Dhochartaigh; Irwin Tran; Iain Leslie; Peter Schmid
Journal:  Health Qual Life Outcomes       Date:  2020-11-02       Impact factor: 3.186

Review 8.  Nanobodies as non-invasive imaging tools.

Authors:  M Rashidian; H Ploegh
Journal:  Immunooncol Technol       Date:  2020-07-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.